Our services

Integrated Decision-Making Across the Development Journey

At Esylos, every engagement starts from the same place: the decision that needs to be made, and what it will take to make it with confidence in the face of uncertainty.

We partner with your team to enable informed decision-making when the path forward is unclear, data is incomplete, and the cost of being wrong is high.

[01]

Development Strategy & Decision Support

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Core capabilities

Causal AI for decision-making under uncertainty

Expert knowledge mapping and elicitation

Risk-centric development planning

[02]

Innovative Clinical Development

Our experts bring a proven track record of innovative trial design and published methods to help teams design optimal studies that deliver results faster and at lower cost without sacrificing rigor or regulatory acceptance.

Open

Close

Core capabilities

Rare disease trial design and execution

Bayesian adaptive clinical designs

Real-world evidence integration and regulatory strategy

[03]

CMC Statistics & Decision Support

Esylos brings causal reasoning, Bayesian decision support, and deep CMC expertise to help life science teams make confident manufacturing decisions — from process characterization through commercial distribution.

Open

Close

Core capabilities

Regulatory-ready CMC across the full lifecycle

DoE & Bayesian optimization for process understanding

Causal reasoning & digital twins for manufacturing decisions

[01]

Development Strategy & Decision Support

Integrating knowledge from the earliest development stage and continuously building a causal graph as evidence accumulates allows teams to see the whole program and make decisions that account for downstream consequences.

Open

Close

Core capabilities

Causal AI for decision-making under uncertainty

Expert knowledge mapping and elicitation

Risk-centric development planning

[02]

Innovative Clinical Development

Our experts bring a proven track record of innovative trial design and published methods to help teams design optimal studies that deliver results faster and at lower cost without sacrificing rigor or regulatory acceptance.

Open

Close

Core capabilities

Rare disease trial design and execution

Bayesian adaptive clinical designs

Real-world evidence integration and regulatory strategy

[03]

CMC Statistics & Decision Support

Esylos brings causal reasoning, Bayesian decision support, and deep CMC expertise to help life science teams make confident manufacturing decisions — from process characterization through commercial distribution.

Open

Close

Core capabilities

Regulatory-ready CMC across the full lifecycle

DoE & Bayesian optimization for process understanding

Causal reasoning & digital twins for manufacturing decisions

Why this matters

When CMC statistics operates in isolation from development strategy, the consequences are predictable: specifications disconnected from clinical relevance, validation strategies that miss the real process risks, design spaces that break at scale, and stability models that create false confidence. These are the issues behind many CMC-related regulatory setbacks — and most are not failures of statistical technique. They are failures of connection between data, decisions, and regulatory argumentation.

Why this matters

When CMC statistics operates in isolation from development strategy, the consequences are predictable: specifications disconnected from clinical relevance, validation strategies that miss the real process risks, design spaces that break at scale, and stability models that create false confidence. These are the issues behind many CMC-related regulatory setbacks — and most are not failures of statistical technique. They are failures of connection between data, decisions, and regulatory argumentation.

Why this matters

When CMC statistics operates in isolation from development strategy, the consequences are predictable: specifications disconnected from clinical relevance, validation strategies that miss the real process risks, design spaces that break at scale, and stability models that create false confidence. These are the issues behind many CMC-related regulatory setbacks — and most are not failures of statistical technique. They are failures of connection between data, decisions, and regulatory argumentation.

How can we help you achieve your goals?

Describe your challenges

group of people using laptop computer

How can we help you achieve your goals?

Describe your challenges

group of people using laptop computer

How can we help you achieve your goals?

Describe your challenges

group of people using laptop computer

Create a free website with Framer, the website builder loved by startups, designers and agencies.